Filter by

JPMorgan 2020 – ForbesBOOKS interview with Dr. Neil Hayward

February 6, 2020 In the News

ForbesBOOKS Radio

Neil Hayward, Ph.D. is CEO of eXIthera; eXIthera is the leader in Factor XIa inhibition, the ideal target for anticoagulation. Their drug candidates are small molecules that prevent thrombosis without an increased risk in bleeding.

Read More